Literature DB >> 19084042

Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats.

Kyoko Nishi1, Kazuya Kanemaru, Shu Hasegawa, Arata Watanabe, Mirko Diksic.   

Abstract

The main objective of this investigation was to evaluate the effects of buspirone, a 5-HT(1A) agonist with some partial agonist properties and also an antidepressant, on regional 5-HT synthesis in Flinders Sensitive Line (FSL) rats ("depressed"), and to compare the effects to the Flinders Resistant Line (FRL) control rats (not "depressed"). In addition results were compared to those previously reported in normal Sprague-Dawley (SPD) rats (normal control). Serotonin synthesis in both FSL and FRL rats was measured following acute and chronic treatments with buspirone. Both of these strains were derived from the SPD rats. No direct comparison was done between the FSL saline and FRL saline groups, or the FSL buspirone and FRL buspirone groups, because the objective of the studies was to evaluate effects of buspirone in these two strains. The results show that acute treatment with buspirone elevates 5-HT synthesis throughout the brain in the FRL rats. In the FSL rats, there were reductions in some brain regions (e.g., dorsal and median raphe, amygdala, anterior olfactory nucleus, substantia nigra reticulate), while in other regions, there were increases in the synthesis observed (e.g., frontal, parietal, visual and somatosensory cortices, ventral hippocampus). In 20 out of the 30 brain regions investigated in the FSL rats, there was no significant change in the synthesis following acute buspirone treatment. During the chronic treatment, buspirone produced a significant reduction of 5-HT synthesis in 15 out of 30 brain regions in the FRL rats. In the FSL rats, buspirone produced a significant elevation of the synthesis in 10 out of 30 brain regions. In both the FSL and FRL rats, buspirone produced rather different effects than those reported previously for SPD (normal) rats. The acute effect in the FSL rats was somewhat similar to the effect reported previously for the SPD rats, while in the FRL rats, the acute buspirone treatment produced an effect observed previously in treatments with 5-HT(1A) antagonists suggesting an action of buspirone as partial agonist in FRL rats. The data suggest that with respect to 5-HT synthesis, FRL rats differ from SPD rats (a natural control; normal rats) and, as such, indicate that when the effects related to the serotonergic system (e.g., influence of serotonergic drugs) are studied in the FSL rats and compared to those in the FRL rats, any conclusions drawn may not reflect differences relative to a normal rat.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084042      PMCID: PMC2693024          DOI: 10.1016/j.neuint.2008.10.010

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  91 in total

Review 1.  A review of central 5-HT receptors and their function.

Authors:  N M Barnes; T Sharp
Journal:  Neuropharmacology       Date:  1999-08       Impact factor: 5.250

2.  Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.

Authors:  A Gobert; J M Rivet; L Cistarelli; C Melon; M J Millan
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

3.  Effects of acute and chronic administration of the serotonin1A agonist buspirone on serotonin synthesis in the rat brain.

Authors:  H Okazawa; F Yamane; P Blier; M Diksic
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

4.  Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone.

Authors:  L N Yatham; P F Liddle; J Dennie; I S Shiah; M J Adam; C J Lane; R W Lam; T J Ruth
Journal:  Arch Gen Psychiatry       Date:  1999-08

5.  The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET.

Authors:  J H Meyer; R Cho; S Kennedy; S Kapur
Journal:  Psychopharmacology (Berl)       Date:  1999-06       Impact factor: 4.530

6.  Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment.

Authors:  A Zangen; D H Overstreet; G Yadid
Journal:  Brain Res       Date:  1999-04-10       Impact factor: 3.252

7.  Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.

Authors:  C L Barton; P H Hutson
Journal:  Synapse       Date:  1999-01       Impact factor: 2.562

Review 8.  Antidepressant-like behavioral effects of serotonin receptor agonists.

Authors:  I Lucki; A Singh; D S Kreiss
Journal:  Neurosci Biobehav Rev       Date:  1994       Impact factor: 8.989

9.  Determination of the lumped constant for the alpha-methyltryptophan method of estimating the rate of serotonin synthesis.

Authors:  M Vanier; K Tsuiki; M Grdisa; K Worsley; M Diksic
Journal:  J Neurochem       Date:  1995-02       Impact factor: 5.372

10.  Effect of acute fluoxetine treatment on the brain serotonin synthesis as measured by the alpha-methyl-L-tryptophan autoradiographic method.

Authors:  K Tsuiki; Y L Yamamoto; M Diksic
Journal:  J Neurochem       Date:  1995-07       Impact factor: 5.372

View more
  5 in total

1.  Reduced metabotropic glutamate receptor 5 in the Flinders Sensitive Line of rats, an animal model of depression: an autoradiographic study.

Authors:  Tomislav Kovačević; Ivan Skelin; Luciano Minuzzi; Pedro Rosa-Neto; Mirko Diksic
Journal:  Brain Res Bull       Date:  2012-01-31       Impact factor: 4.077

2.  The lumped constant of α-methyl-l-tryptophan is not influenced by drugs acting through serotonergic system.

Authors:  Nela Pivac; Mirko Diksic
Journal:  Neurochem Int       Date:  2011-03-22       Impact factor: 3.921

3.  The opposite effect of a 5-HT1B receptor agonist on 5-HT synthesis, as well as its resistant counterpart, in an animal model of depression.

Authors:  Ivan Skelin; Tomislav Kovačević; Hiroki Sato; Mirko Diksic
Journal:  Brain Res Bull       Date:  2012-04-20       Impact factor: 4.077

Review 4.  The recent progress in animal models of depression.

Authors:  Qingzhong Wang; Matthew A Timberlake; Kevin Prall; Yogesh Dwivedi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-04-08       Impact factor: 5.067

5.  Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration.

Authors:  T M Eriksson; P Delagrange; M Spedding; M Popoli; A A Mathé; S O Ögren; P Svenningsson
Journal:  Mol Psychiatry       Date:  2011-01-18       Impact factor: 15.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.